vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and KILROY REALTY CORP (KRC). Click either name above to swap in a different company.
KILROY REALTY CORP is the larger business by last-quarter revenue ($272.2M vs $207.8M, roughly 1.3× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 6.3%, a 51.1% gap on every dollar of revenue. KILROY REALTY CORP produced more free cash flow last quarter ($450.3M vs $142.2M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Kilroy Realty Corp is a leading U.S. real estate investment trust that develops, owns, and operates premium office, life science, and mixed-use properties primarily across high-growth West Coast markets including Los Angeles, San Francisco, Seattle, and San Diego. It serves tenants across the technology, life sciences, media, and creative sectors, with a core focus on delivering sustainable, future-ready workspaces tailored to modern business needs.
IDYA vs KRC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $272.2M |
| Net Profit | $119.2M | $17.1M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | — |
| Net Margin | 57.4% | 6.3% |
| Revenue YoY | — | -5.0% |
| Net Profit YoY | 330.1% | -73.7% |
| EPS (diluted) | $1.33 | $0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $272.2M | ||
| Q3 25 | $207.8M | $279.7M | ||
| Q2 25 | — | $289.9M | ||
| Q1 25 | — | $270.8M | ||
| Q4 24 | — | $286.4M | ||
| Q3 24 | $0 | $289.9M | ||
| Q2 24 | $0 | $280.7M | ||
| Q1 24 | $0 | $278.6M |
| Q4 25 | — | $17.1M | ||
| Q3 25 | $119.2M | $162.3M | ||
| Q2 25 | — | $79.6M | ||
| Q1 25 | — | $43.7M | ||
| Q4 24 | — | $65.0M | ||
| Q3 24 | $-51.8M | $57.7M | ||
| Q2 24 | $-52.8M | $54.5M | ||
| Q1 24 | $-39.6M | $55.7M |
| Q4 25 | — | — | ||
| Q3 25 | 52.2% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 6.3% | ||
| Q3 25 | 57.4% | 58.0% | ||
| Q2 25 | — | 27.4% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 22.7% | ||
| Q3 24 | — | 19.9% | ||
| Q2 24 | — | 19.4% | ||
| Q1 24 | — | 20.0% |
| Q4 25 | — | $0.11 | ||
| Q3 25 | $1.33 | $1.31 | ||
| Q2 25 | — | $0.57 | ||
| Q1 25 | — | $0.33 | ||
| Q4 24 | — | $0.50 | ||
| Q3 24 | $-0.60 | $0.44 | ||
| Q2 24 | $-0.68 | $0.41 | ||
| Q1 24 | $-0.53 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $179.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $5.4B |
| Total Assets | $1.2B | $10.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $179.3M | ||
| Q3 25 | $786.9M | $372.4M | ||
| Q2 25 | — | $193.1M | ||
| Q1 25 | — | $146.7M | ||
| Q4 24 | — | $165.7M | ||
| Q3 24 | $920.0M | $625.4M | ||
| Q2 24 | $701.7M | $835.9M | ||
| Q1 24 | $698.8M | $855.0M |
| Q4 25 | — | $5.4B | ||
| Q3 25 | $1.1B | $5.5B | ||
| Q2 25 | — | $5.4B | ||
| Q1 25 | — | $5.4B | ||
| Q4 24 | — | $5.4B | ||
| Q3 24 | $1.2B | $5.4B | ||
| Q2 24 | $931.7M | $5.4B | ||
| Q1 24 | $935.3M | $5.4B |
| Q4 25 | — | $10.9B | ||
| Q3 25 | $1.2B | $11.0B | ||
| Q2 25 | — | $10.9B | ||
| Q1 25 | — | $10.9B | ||
| Q4 24 | — | $10.9B | ||
| Q3 24 | $1.2B | $11.4B | ||
| Q2 24 | $973.7M | $11.5B | ||
| Q1 24 | $961.5M | $11.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $566.3M |
| Free Cash FlowOCF − Capex | $142.2M | $450.3M |
| FCF MarginFCF / Revenue | 68.4% | 165.4% |
| Capex IntensityCapex / Revenue | 0.0% | 42.6% |
| Cash ConversionOCF / Net Profit | 1.19× | 33.10× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $833.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $566.3M | ||
| Q3 25 | $142.2M | $176.6M | ||
| Q2 25 | — | $143.7M | ||
| Q1 25 | — | $136.9M | ||
| Q4 24 | — | $541.1M | ||
| Q3 24 | $-49.2M | $176.3M | ||
| Q2 24 | $-32.9M | $88.7M | ||
| Q1 24 | $-43.8M | $167.9M |
| Q4 25 | — | $450.3M | ||
| Q3 25 | $142.2M | $148.7M | ||
| Q2 25 | — | $118.4M | ||
| Q1 25 | — | $115.6M | ||
| Q4 24 | — | $440.8M | ||
| Q3 24 | $-49.7M | $147.2M | ||
| Q2 24 | $-33.9M | $69.5M | ||
| Q1 24 | $-45.1M | $151.9M |
| Q4 25 | — | 165.4% | ||
| Q3 25 | 68.4% | 53.1% | ||
| Q2 25 | — | 40.9% | ||
| Q1 25 | — | 42.7% | ||
| Q4 24 | — | 153.9% | ||
| Q3 24 | — | 50.8% | ||
| Q2 24 | — | 24.7% | ||
| Q1 24 | — | 54.5% |
| Q4 25 | — | 42.6% | ||
| Q3 25 | 0.0% | 10.0% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 7.9% | ||
| Q4 24 | — | 35.0% | ||
| Q3 24 | — | 10.1% | ||
| Q2 24 | — | 6.8% | ||
| Q1 24 | — | 5.7% |
| Q4 25 | — | 33.10× | ||
| Q3 25 | 1.19× | 1.09× | ||
| Q2 25 | — | 1.81× | ||
| Q1 25 | — | 3.13× | ||
| Q4 24 | — | 8.32× | ||
| Q3 24 | — | 3.06× | ||
| Q2 24 | — | 1.63× | ||
| Q1 24 | — | 3.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
